Recombinant clotting factor VIII

This page covers all Recombinant clotting factor VIII drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Factor VIII (coagulation factor VIII).

Targets

Factor VIII (coagulation factor VIII)

Marketed (1)

• Afstyla® · CSL Behring · Hematology
  Afstyla is a recombinant antithrombin III-free factor VIII that replaces deficient clotting factor VIII to restore hemostasis in patients with hemophilia A.

Phase 3 pipeline (1)

• rVIII-SingleChain · CSL Behring · Hematology
  rVIII-SingleChain is a recombinant single-chain factor VIII that replaces deficient clotting factor VIII to restore hemostasis in hemophilia A patients.